|
1
|
Detterbeck FC, Postmus PE and Tanoue LT:
The stage classification of lung cancer: Diagnosis and management
of lung cancer, 3rd edition. American college of chest physicians
evidence-based clinical practice guidelines. Chest. 143(Suppl 5):
e191S–e210S. 2013.
|
|
2
|
Chen Z, Xu Z, Sun S, Yu Y, Lv D, Cao C and
Deng Z: TGF-β1, IL-6 and TNF-α in bronchoalveolar lavage fluid:
Useful markers for lung cancer? Sci Rep. 4:55952014.PubMed/NCBI
|
|
3
|
Chyczewska E, Mróz RM and Kowal E:
TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage
fluid (BALF) of non-small cell lung cancer (NSCLC). Rocz Akad Med
Bialymst. 42(Suppl 1): S123–S135. 1997.
|
|
4
|
Liu H, Zhang T, Ye J, Li H, Huang J, Li X,
Wu B, Huang X and Hou J: TNF receptor-associated factor 6 in
advanced non-small cell lung cancer: Clinical and prognostic
implications. J Cancer Res Clin Oncol. 138:1853–1863. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Connell C, Hensey M, Mongey AB, Veale DJ
and Donnelly SC: A series of patients on anti-TNF therapy referred
to a multidisciplinary lung cancer service. Ir J Med Sci.
182:135–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seifart C, Plagens A, Dempfle A,
Clostermann U, Vogelmeier C, von Wichert P and Seifart U:
TNF-alpha, TNF-beta, IL-6 and IL-10 polymorphisms in patients with
lung cancer. Dis Markers. 21:157–165. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie H, Yao H, Huo Y, Li N and Cheng Y:
Association between TNF-α gene 308G>A polymorphism and lung
cancer risk: A meta-analysis. Tumour Biol. 35:9693–9699. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang B and Wu Y: The preoperative and
postoperative changes of T lymphocyte subsets and TNF in patients
with locally advanced lung cancer. Zhongguo Fei Ai Za Zhi. 2:67–69.
1999.(In Chinese). PubMed/NCBI
|
|
9
|
Hahne M, Kataoka T, Schröter M, Hofmann K,
Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE,
et al: APRIL, a new ligand of the tumor necrosis factor family,
stimulates tumor cell growth. J Exp Med. 188:1185–1190. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moreaux J, Veyrune JL, De Vos J and Klein
B: APRIL is overexpressed in cancer: Link with tumor progression.
BMC Cancer. 9:832009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Notas G, Alexaki VI, Kampa M, Pelekanou V,
Charalampopoulos I, Sabour-Alaoui S, Pediaditakis I, Dessirier V,
Gravanis A, Stathopoulos EN, et al: APRIL binding to BCMA activates
a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest
in liver cells. J Immunol. 189:4748–4758. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak and Schmittgen, . Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia-Castro A, Zonca M,
Florindo-Pinheiro D, Carvalho-Pinto CE, Cordero A, Gutiérrez del
Fernando B, García-Grande A, Mañes S, Hahne M, González-Suárez E
and Planelles L: APRIL promotes breast tumor growth and metastasis
and is associated with aggressive basal breast cancer.
Carcinogenesis. 36:574–584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim CH, Han SI, Lee SY, Youk HS, Moon JY,
Duong HQ, Park MJ, Joo YM, Park HG, Kim YJ, et al: Protein kinase
C-ERK1/2 signal pathway switches glucose depletion-induced necrosis
to apoptosis by regulating superoxide dismutases and suppressing
reactive oxygen species production in A549 lung cancer cells. J
Cell Physiol. 211:371–385. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ko JC, Ciou SC, Jhan JY, Cheng CM, Su YJ,
Chuang SM, Lin ST, Chang CC and Lin YW: Roles of MKK1/2-ERK1/2 and
phosphoinositide 3-kinase-AKT signaling pathways in
erlotinib-induced Rad51 suppression and cytotoxicity in human
non-small cell lung cancer cells. Mol Cancer Res. 7:1378–1389.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vicent S, Lopez-Picazo JM, Toledo G,
Lozano MD, Torre W, Garcia-Corchón C, Quero C, Soria JC,
Martín-Algarra S, Manzano RG and Montuenga LM: ERK1/2 is activated
in non-small-cell lung cancer and associated with advanced tumours.
Br J Cancer. 90:1047–1052. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H, Wu C, Wan S, Zhang H, Zhou S and
Liu G: Shikonin attenuates lung cancer cell adhesion to
extracellular matrix and metastasis by inhibiting integrin β1
expression and the ERK1/2 signaling pathway. Toxicology.
308:104–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang M, Liu ZM, Li XC, Yao YT and Yin ZX:
Activation of ERK1/2 and Akt is associated with cisplatin
resistance in human lung cancer cells. J Chemother. 25:162–169.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mhawech-Fauceglia P, Kaya G, Sauter G,
McKee T, Donze O, Schwaller J and Huard B: The source of APRIL
up-regulation in human solid tumor lesions. J Leukoc Biol.
80:697–704. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mhawech-Fauceglia P, Allal A, Odunsi K,
Andrews C, Herrmann FR and Huard B: Role of the tumour necrosis
family ligand APRIL in solid tumour development: Retrospective
studies in bladder, ovarian and head and neck carcinomas. Eur J
Cancer. 44:2097–2100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pelekanou V, Notas G, Theodoropoulou K,
Kampa M, Takos D, Alexaki VI, Radojicic J, Sofras F, Tsapis A,
Stathopoulos EN and Castanas E: Detection of the TNFSF members
BAFF, APRIL, TWEAK and their receptors in normal kidney and renal
cell carcinomas. Anal Cell Pathol (Amst). 34:49–60. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pelekanou V, Notas G, Kampa M,
Tsentelierou E, Stathopoulos EN, Tsapis A and Castanas E: BAFF,
APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human
glioma tumor grade: Immunohistochemistry and public microarray data
meta-analysis. PloS One. 8:e832502013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang F, Chen L, Mao ZB, Shao JG, Tan C and
Huang WD: Lentivirus-mediated short hairpin RNA targeting the APRIL
gene suppresses the growth of pancreatic cancer cells in vitro and
in vivo. Oncol Rep. 20:135–139. 2008.PubMed/NCBI
|
|
24
|
Lascano V, Zabalegui LF, Cameron K,
Guadagnoli M, Jansen M, Burggraaf M, Versloot M, Rodermond H, van
der Loos C, Carvalho-Pinto CE, et al: The TNF family member APRIL
promotes colorectal tumorigenesis. Cell Death Differ. 19:1826–1835.
2012. View Article : Google Scholar : PubMed/NCBI
|
